MSMarko Simunovic

Marko Simunovic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marko Simunovic has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Angela Coates

    From the Departments of *Surgery and †Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University, the ‡Juravinski Cancer Centre, Hamilton, Ont., the §Surveillance Unit, Division of Preventive Oncology, Cancer Care Ontario, and the ¶Department of Surgery, University of Toronto and University Health Network, Toronto, Ont

    2 shared publications
  • Eddy Rempel

    From the Departments of *Surgery and †Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University, the ‡Juravinski Cancer Centre, Hamilton, Ont., the §Surveillance Unit, Division of Preventive Oncology, Cancer Care Ontario, and the ¶Department of Surgery, University of Toronto and University Health Network, Toronto, Ont

    2 shared publications
  • Eric Holowaty

    From the Departments of *Surgery and †Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University, the ‡Juravinski Cancer Centre, Hamilton, Ont., the §Surveillance Unit, Division of Preventive Oncology, Cancer Care Ontario, and the ¶Department of Surgery, University of Toronto and University Health Network, Toronto, Ont

    2 shared publications
  • Marc-Erick Thériault

    From the Departments of *Surgery and †Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University, the ‡Juravinski Cancer Centre, Hamilton, Ont., the §Surveillance Unit, Division of Preventive Oncology, Cancer Care Ontario, and the ¶Department of Surgery, University of Toronto and University Health Network, Toronto, Ont

    2 shared publications
  • Mark Levine

    From the Departments of *Surgery and †Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University, the ‡Juravinski Cancer Centre, Hamilton, Ont., the §Surveillance Unit, Division of Preventive Oncology, Cancer Care Ontario, and the ¶Department of Surgery, University of Toronto and University Health Network, Toronto, Ont

    2 shared publications
  • Timothy Whelan

    From the Departments of *Surgery and †Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University, the ‡Juravinski Cancer Centre, Hamilton, Ont., the §Surveillance Unit, Division of Preventive Oncology, Cancer Care Ontario, and the ¶Department of Surgery, University of Toronto and University Health Network, Toronto, Ont

    2 shared publications

Latest Publications

  • Open Access

    The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery

    by Marko Simunovic, Charles Goldsmith, Lehana Thabane, Robin McLeod, Franco DeNardi, Timothy J Whelan, Mark N Levine

    Two unfortunate outcomes for patients treated surgically for rectal cancer are placement of a permanent colostomy and local tumor recurrence. Total mesorectal excision is a new technique for rectal cancer surgery that can lead to improved patient outcomes. We describe a cluster randomized controlled trial that is testing if the above patient outcomes can be improved through a knowledge translation strategy called the Quality Initiative in Rectal Cancer (QIRC) strategy. The strategy is designed to optimize the use of total mesorectal excision techniques.


    • 1 August 2006
      • Vol. 49  (4) , 251-8

    Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario.

    by Marko Simunovic, Eddy Rempel, Marc-Erick Thériault, Angela Coates, Timothy Whelan, Eric Holowaty, Bernard Langer, Mark Levine

    There is a lack of information from Canadian hospitals on the role of hospital characteristics such as procedure volume and teaching status on the survival of patients who undergo major cancer resection. Therefore, we chose to study these relationships using data from patients treated in Ontario hospitals. We used the Ontario Cancer Registry from calendar years 1990-2000 to obtain data on patients who underwent surgery for breast, colon, lung or esophageal cancer or who underwent major liver surgery related to a cancer diagnosis between 1990 and 1995 in order to assess the influence of volume of procedures and teaching status of hospitals on in-hospital death rate and long-term survival. For each disease site and before observing patient outcomes data, volume cut-off points were selected to create volume groups with similar numbers of patients. Teaching hospitals were those directly affiliated with a medical school. Logistic regression and proportional hazards models were used to consider the clustering of data at the hospital level and to assess operative death and long-term survival. We also used 4 measures to gauge the degree of procedure regionalization across the province including (1) the number of hospitals performing a procedure; (2) the percentage of patients treated in teaching hospitals; (3) the percentage of rural patients treated in higher volume procedure hospitals; and (4) median distances travelled by patients to receive care. The number of patients in our cohorts who underwent resection of the breast, colon, lung, esophagus or liver was 14 346, 8398, 2698, 629 and 362, respectively. Surgery in a high-volume versus a low-volume hospital did not have a statistically significant influence on the odds of operative death for patients who underwent colon, liver, lung or esophageal cancer resection. The risk of long-term death was increased in low-volume versus high-volume hospitals for patients who underwent resection of the breast (hazard ratio [HR] 1.2, 95% confidence interval [95% CI] 1.0-1.4, p < 0.05), lung (HR 1.3, 95% CI 1.1-1.6, p < 0.01) and liver (HR 1.7, 95% CI 1.0-2.7, p = 0.04). There were no significant differences in the odds of operative (in-hospital) death or risk of long-term death among patients treated in teaching compared with nonteaching hospitals. There was more regionalization of liver, lung and esophageal operations versus breast and colon operations. Increased hospital procedure volume correlated with improved longterm survival for patients in Ontario who underwent some, but not all, cancer resections, whereas hospital teaching status had no significant impact on patient outcomes. Across the province, further regionalization of care may help improve the quality of some cancer procedures.


  • Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: A population-based study

    by Luke Bui, Eddy Rempel, Dana Reeson, Marko Simunovic

    Background and Objectives This study assessed lymph node counts, lymph node status (positive or negative), and survival among patients undergoing colon cancer surgery in Ontario, Canada. Methods We obtained data from the Ontario Cancer Registry on 960 patients who underwent a major colon cancer resection in years 1991–1993. Patients and hospitals were ranked by lymph node count to correlate lymph node counts and lymph node status. For node-negative patients we assessed the influence of patient, hospital, and tumor factors on lymph node counts and survival. Results The rate of node-positive patients was similar among the lymph node count groups. For example, the odds ratio of a patient being node positive if the lymph node count was 10–36 versus 1–3 was 1.0 (CI 0.6–1.6, P = 0.42). Among node-negative patients, survival was improved for patients with a high (10–36) versus low (1–3) lymph node count (HR 0.6, CI 0.4–1.0, P = 0.03). No patient, hospital, or tumor factors predicted both a higher lymph node count and improved survival. Conclusions In this population-based study of patients undergoing colon cancer surgery, higher lymph node counts did not correlate with increased rates of node-positive status. J. Surg. Oncol. 2006;93:439–445.


    • 1 April 2005
      • Vol. 48  (2) , 137-42

    Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000.

    by Marko Simunovic, Marc-Erick Thériault, Lawrence Paszat, Angela Coates, Timothy Whelan, Eric Holowaty, Mark Levine

    To determine how long patients in Ontario waited for major breast, colorectal, lung or prostate cancer surgery in the years 1993-2000. "Surgical waiting time" was defined as the interval from date of preoperative surgeon consult to date of hospital admission for surgery. We created patient cohorts by linking appropriate diagnosis and procedure codes from Canadian Institutes of Health Information data. Scrambled unique surgeon identifiers were obtained from Ontario Health Insurance Plan data. Changes in median surgical waiting times were assessed with univariate time-trend analyses and multilevel models. Models were controlled for year of surgery and other patient (age, gender, comorbid conditions, income level, area of residence) and hospital level characteristics (teaching status, procedure volume status). Compared with 1993, median surgical waiting times in the year 2000 increased 36% for patients with breast cancer (to 19 d), 46% with colorectal (to 19 d), 36% with lung (to 34 d) and 4% with prostate cancer (to 83 d). Multilevel models confirmed significant increases in waiting times for all procedures. There were no concerning or consistent differences in waiting times among the categories of hospitals and patients examined. There were significant increases in surgical waiting times among patients undergoing breast, colorectal, lung or prostate cancer surgery in Ontario over years 1993-2000. Administrative databases can be used to efficiently measure such waits.


  • Pilot Study of the Quality Initiative in Rectal Cancer Strategy

    by Marko I. Simunovic, Craig A. Paterson, Angela J. Coates, James R. Wright, Mark N. Levine

    INTRODUCTION:Total mesorectal excisionvs. traditional surgical techniques may lead to improved rates of permanent colostomy, local tumor recurrence, and survival for patients undergoing major rectal cancer operations. We developed the surgeon-directed, multipronged Quality Initiative in Rectal Cance


  • Open Access

    Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy

    by M Simunovic, R Sexton, E Rempel, B J Moran, R J Heald

    Background: Radiation is being used increasingly in the management of patients with rectal cancer. Over the past decade the Basingstoke Colorectal Research Unit has combined precision total mesorectal excision with the highly selective use of preoperative radiotherapy. Methods: One hundred and fifty consecutive patients who underwent major surgical excision for cancers of all stages comprised the study group. Preoperative clinical assessment was based largely on tumour size, fixation and distance from the anal verge. Only preoperative radiotherapy was considered and this only for tumours judged to be at high risk of mesorectal fascia involvement. Results: During a 5-year period 35 of 150 patients were selected for preoperative irradiation. In the non-irradiated patients the local recurrence rate after a median follow-up period of 870 (range 51–1903) days was 2·6 per cent (three of 115 patients), compared with 17·1 per cent (six of 35 patients) in those chosen for irradiation. Sixty patients (52·2 per cent) who were not irradiated were node positive. The local recurrence rate for the whole group was 6·0 per cent. Conclusion: The great majority of patients undergoing major excision for rectal cancer can be managed without radiation therapy if the preoperative assessment of the mesorectal fascia and surgery are performed optimally.